Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Dahlöf

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|December 5, 2002
Sumatriptan: pharmacological basis and clinical resultsC G Dahlöf
Cephalalgia : an International Journal of Headache|October 1, 1995
Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal studyC G Dahlöf
Lakartidningen|December 8, 1998
[New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses]C G Dahlöf
Cephalalgia : an International Journal of Headache|October 1, 1995
How does sumatriptan perform in clinical practice?C G Dahlöf
Headache|March 31, 2001
Sumatriptan injection and tablets in clinical practice: results of a survey of 707 migraineursC G Dahlöf, J Saiers
Cephalalgia : an International Journal of Headache|February 1, 1995
Migraine patients experience poorer subjective well-being/quality of life even between attacksC G Dahlöf, E Dimenäs
Cephalalgia : an International Journal of Headache|April 1, 1996
Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headacheC G Dahlöf, L D Jacobs
Cephalalgia : an International Journal of Headache|January 7, 1999
Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?C G Dahlöf, R J Hargreaves
International Journal of Clinical Practice|October 21, 2005
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraineG Sandrini, C G Dahlöf, N Mathew, et al.
Cephalalgia : an International Journal of Headache|November 25, 1998
Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptanC G Dahlöf, L Falk, M Risenfors, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|December 5, 2002
Sumatriptan: pharmacological basis and clinical resultsC G Dahlöf
Cephalalgia : an International Journal of Headache|October 1, 1995
Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal studyC G Dahlöf
Lakartidningen|December 8, 1998
[New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses]C G Dahlöf
Cephalalgia : an International Journal of Headache|October 1, 1995
How does sumatriptan perform in clinical practice?C G Dahlöf
Headache|March 31, 2001
Sumatriptan injection and tablets in clinical practice: results of a survey of 707 migraineursC G Dahlöf, J Saiers
Cephalalgia : an International Journal of Headache|February 1, 1995
Migraine patients experience poorer subjective well-being/quality of life even between attacksC G Dahlöf, E Dimenäs
Cephalalgia : an International Journal of Headache|April 1, 1996
Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headacheC G Dahlöf, L D Jacobs
Cephalalgia : an International Journal of Headache|January 7, 1999
Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?C G Dahlöf, R J Hargreaves
International Journal of Clinical Practice|October 21, 2005
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraineG Sandrini, C G Dahlöf, N Mathew, et al.
Cephalalgia : an International Journal of Headache|November 25, 1998
Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptanC G Dahlöf, L Falk, M Risenfors, et al.
Pageof 2